NASDAQ Composite ended the session with Biogen jumping 2.99% to $275.31 on Monday while nASDAQ Composite fell 0.48% to $13,895.12.
Biogen today’s close was $275.31, 32.19% below its 52-week high of $363.92.
The company’s growth estimates for the present quarter and the next is a negative 54.8% and a negative 49%, respectively.
Year-on-year quarterly revenue growth declined by 23.8%, now sitting on 12.6B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Biogen’s stock is considered to be overbought (>=80).
Biogen’s Stock Yearly Top and Bottom Value
Biogen’s stock is valued at $275.31 at 17:16 EST, way under its 52-week high of $363.92 and way above its 52-week low of $223.25.
Biogen’s Moving Average
Biogen’s worth is higher than its 50-day moving average of $271.62 and above its 200-day moving average of $265.11.
More news about Biogen.